ArticleClinical ophthalmology (Auckland, N.Z.)2025
Optic Nerve Head Structural Changes After Intravitreal Injection.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the acute anatomical changes of Bruch's membrane opening (BMO) and optic nerve head (ONH) pit depth in patients receiving 0.05cc of anti-VEGF intravitreal injections (IVIs). Methods: We prospectively enrolled patients receiving IVIs and collected data including age, sex, race, phakic status, presence or absence of glaucoma, injection agent utilized, axial length, and cup-to-disc ratio (C/D). High-resolution spectral domain OCT imaging and measurements were made pre- and within five minutes post-IVI. Results: Fifty-one eyes of 51 patients were included in the study. 35.29% of patients were male. The mean age at the time of IVI was 78.27 ± 11.17 years. The average change in the pit depth after IVI was 31.57 ± 24.36 μm (p < 0.001). The number of IVIs previously received significantly correlated with a decreased change in pit depth post-injection (r = -0.369, p = 0.004). No significant relationship was identified between categorical or continuous variables and the change in pit depth or BMO after IVI. No significant associations were identified between the magnitude of IOP elevation and the change in pit depth post-IVI (r = 0.03, p = 0.834) or the number of previous IVIs (r = 0.005, p = 0.973). Conclusion: IVI was associated with a modest increase in ONH pit depth. The number of prior injections inversely correlated with this change, suggesting a potential cumulative effect on structural response. Given the link between ONH biomechanics and retinal nerve fiber layer (RNFL) thinning, our findings raise the possibility that repeated IVIs may contribute to structural changes relevant to glaucomatous progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.